Harnessing the Versatility of Bacterial Collagen to Improve the Chondrogenic Potential of Porous Collagen Scaffolds.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 27219220)

Published in Adv Healthc Mater on May 24, 2016

Authors

Paresh A Parmar1,2, Jean-Philippe St-Pierre1, Lesley W Chow1, Jennifer L Puetzer1, Violet Stoichevska2, Yong Y Peng2, Jerome A Werkmeister2, John A M Ramshaw2, Molly M Stevens1

Author Affiliations

1: Department of Materials, Department of Bioengineering, Institute of Biomedical Engineering, Imperial College London, SW7 2AZ, UK.
2: The Commonwealth Scientific and Industrial Research Organisation (CSIRO) Manufacturing, Bayview Avenue, Clayton, Victoria, 3169, Australia.

Articles cited by this

Tissue engineering. Science (1993) 19.65

Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol (2007) 10.17

Prevalence and most common causes of disability among adults--United States, 2005. MMWR Morb Mortal Wkly Rep (2009) 4.86

Complexity in biomaterials for tissue engineering. Nat Mater (2009) 4.38

Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors. Biotechniques (2005) 2.55

Autologous chondrocyte implantation: a long-term follow-up. Am J Sports Med (2010) 2.43

The effect of matrix stiffness on the differentiation of mesenchymal stem cells in response to TGF-β. Biomaterials (2011) 1.93

Collagen scaffolds for tissue engineering. Biopolymers (2008) 1.91

Unlike bone, cartilage regeneration remains elusive. Science (2012) 1.90

The enhancement of chondrogenic differentiation of human mesenchymal stem cells by enzymatically regulated RGD functionalities. Biomaterials (2008) 1.82

The mechanobiology of articular cartilage development and degeneration. Clin Orthop Relat Res (2004) 1.79

Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation--United States, 2010-2012. MMWR Morb Mortal Wkly Rep (2013) 1.73

[The microfracture technic in the management of complete cartilage defects in the knee joint]. Orthopade (1999) 1.67

The development of articular cartilage: evidence for an appositional growth mechanism. Anat Embryol (Berl) (2001) 1.54

Arthroscopic abrasion arthroplasty historical and pathologic perspective: present status. Arthroscopy (1986) 1.52

Autologous chondrocyte implantation in a novel alginate-agarose hydrogel: outcome at two years. J Bone Joint Surg Br (2008) 1.39

Articular cartilage collagen: an irreplaceable framework? Eur Cell Mater (2006) 1.37

CD44-anchored hyaluronan-rich pericellular matrices: an ultrastructural and biochemical analysis. Exp Cell Res (1996) 1.37

A requirement for the CD44 cytoplasmic domain for hyaluronan binding, pericellular matrix assembly, and receptor-mediated endocytosis in COS-7 cells. J Biol Chem (2002) 1.34

Pharmacologic therapy for osteoarthritis--the era of disease modification. Nat Rev Rheumatol (2010) 1.34

CD44 and integrin matrix receptors participate in cartilage homeostasis. Cell Mol Life Sci (2002) 1.26

Cartilage repair: past and future--lessons for regenerative medicine. J Cell Mol Med (2009) 1.24

The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families. Arterioscler Thromb Vasc Biol (2005) 1.19

Hyaluronic acid enhances proliferation and chondroitin sulfate synthesis in cultured chondrocytes embedded in collagen gels. J Cell Physiol (1999) 1.18

A bioresponsive hydrogel tuned to chondrogenesis of human mesenchymal stem cells. FASEB J (2011) 1.14

Regulation of the chondrogenic phenotype in culture. Birth Defects Res C Embryo Today (2009) 1.13

Controlling cartilaginous matrix evolution in hydrogels with degradation triggered by exogenous addition of an enzyme. Tissue Eng (2007) 1.12

Mesenchymal stem cells and cartilage in situ regeneration. J Intern Med (2009) 1.07

Matrix-induced autologous chondrocyte implantation (MACI): biological and histological assessment. Tissue Eng (2007) 1.06

The effect of dehydrothermal treatment on the mechanical and structural properties of collagen-GAG scaffolds. J Biomed Mater Res A (2009) 1.05

Hypertrophic cartilage matrix. Type X collagen, supramolecular assembly, and calcification. Ann N Y Acad Sci (1990) 1.03

Localization of type X collagen in canine growth plate and adult canine articular cartilage. J Orthop Res (1991) 1.03

Bioactive hydrogels based on Designer Collagens. Acta Biomater (2010) 1.02

A Streptococcus pyogenes derived collagen-like protein as a non-cytotoxic and non-immunogenic cross-linkable biomaterial. Biomaterials (2010) 1.02

Anisotropic fibrous scaffolds for articular cartilage regeneration. Tissue Eng Part A (2012) 1.01

Collagen fibres with improved strength for the repair of soft tissue injuries. Biomaterials (1994) 1.01

Hyaluronan and CD44: strategic players for cell-matrix interactions during chondrogenesis and matrix assembly. Birth Defects Res C Embryo Today (2003) 0.99

Recombinant protein scaffolds for tissue engineering. Biomed Mater (2012) 0.98

Collagen type I hydrogel allows migration, proliferation, and osteogenic differentiation of rat bone marrow stromal cells. J Biomed Mater Res A (2010) 0.97

Glued periosteal grafts in the knee. Acta Orthop Scand (1985) 0.96

Expression of CD44 in articular cartilage is associated with disease severity in knee osteoarthritis. Mod Rheumatol (2013) 0.93

Effect of three-dimensional expansion and cell seeding density on the cartilage-forming capacity of human articular chondrocytes in type II collagen sponges. J Biomed Mater Res A (2010) 0.93

Engineering multiple biological functional motifs into a blank collagen-like protein template from Streptococcus pyogenes. J Biomed Mater Res A (2013) 0.93

Towards scalable production of a collagen-like protein from Streptococcus pyogenes for biomedical applications. Microb Cell Fact (2012) 0.93

In vivo tissue engineering of musculoskeletal tissues. Curr Opin Biotechnol (2011) 0.92

The use of type 1 collagen scaffold containing stromal cell-derived factor-1 to create a matrix environment conducive to partial-thickness cartilage defects repair. Biomaterials (2012) 0.91

Hydrogels of collagen/chondroitin sulfate/hyaluronan interpenetrating polymer network for cartilage tissue engineering. J Mater Sci Mater Med (2012) 0.90

Combinatorial scaffold morphologies for zonal articular cartilage engineering. Acta Biomater (2013) 0.90

An improved collagen scaffold for skeletal regeneration. J Biomed Mater Res A (2010) 0.88

Electrostatic interactions modulate the conformation of collagen I. Biophys J (2007) 0.87

In vitro proliferation and chondrogenic differentiation of rat bone marrow stem cells cultured with gelatin hydrogel microspheres for TGF-beta1 release. J Biomater Sci Polym Ed (2010) 0.87

The incorporation of a zone of calcified cartilage improves the interfacial shear strength between in vitro-formed cartilage and the underlying substrate. Acta Biomater (2011) 0.85

Peptide-directed spatial organization of biomolecules in dynamic gradient scaffolds. Adv Healthc Mater (2014) 0.85

MACI - a new era? Sports Med Arthrosc Rehabil Ther Technol (2011) 0.84

Simultaneous arthroscopic implantation of autologous chondrocytes and high tibial osteotomy for tibial chondral defects in the varus knee. Knee (2008) 0.83

A simple cost-effective methodology for large-scale purification of recombinant non-animal collagens. Appl Microbiol Biotechnol (2014) 0.82

Dehydrothermal crosslinking of electrospun collagen. Tissue Eng Part C Methods (2010) 0.82

Collagen-mimetic peptide-modifiable hydrogels for articular cartilage regeneration. Biomaterials (2015) 0.81

A novel implantation technique for engineered osteo-chondral grafts. Knee Surg Sports Traumatol Arthrosc (2009) 0.81

Using a type 1 collagen-based system to understand cell-scaffold interactions and to deliver chimeric collagen-binding growth factors for vascular tissue engineering. J Investig Med (2010) 0.81

Tonsillectomy and adenoidectomy. Pediatr Rev (2005) 0.80

Interaction of hyaluronan binding peptides with glycosaminoglycans in poly(ethylene glycol) hydrogels. Biomacromolecules (2014) 0.80

Clinical aspects of the effect of NSAID on cartilage. J Rheumatol Suppl (1989) 0.78

[Experiences with a cartilage-bone marrow extract in the treatment of rheumatic joint diseases]. Z Alternsforsch (1971) 0.78

[Implantation of autologous chondrocytes for cartilagenous lesions in young patients. A study of 24 cases]. Chirurgie (1998) 0.78

Tibial cartilage hypertrophy due to matrix-associated autologous chondrocyte transplantation of the medial femoral condyle. A case report. J Bone Joint Surg Am (2009) 0.77